QT
BCYC

Quantbot Technologies’s Bicycle Therapeutics BCYC Stock Holding History

Quantbot Technologies’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-400
Closed -$7.23K – 1561
2023
Q4 		$7.23K Buy
400
+100
+33% +$1.65K ﹤0.01% 1477
2023
Q3 		$6.03K Buy
+300
New +$6.86K ﹤0.01% 1443
2023
Q2 		– Sell
-300
Closed -$6.38K – 1580
2023
Q1 		$6.38K Buy
+300
New +$7.52K ﹤0.01% 1432
2022
Q3 		– Sell
-3,612
Closed -$60K – 1607
2022
Q2 		$60K Buy
+3,612
New +$76.2K 0.01% 1265
2022
Q1 		– Sell
-559
Closed -$34K – 1642
2021
Q4 		$34K Buy
+559
New +$30.8K ﹤0.01% 1124

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Quantbot Technologies's BCYC Position: Q1 2024 in Review

Quantbot Technologies sold out of Bicycle Therapeutics (BCYC) in Q1 2024, closing a stake of 400 shares — an estimated $7.23K sold.

Quantbot Technologies first reported a position in BCYC in Q4 2021 and held it in 5 quarters. The position peaked at $60K in Q2 2022. 95 funds tracked by Wall St. Rank hold BCYC as of Q1 2024.

  • Quantbot Technologies reported no remaining Bicycle Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Quantbot Technologies sold 400 Bicycle Therapeutics shares in Q1 2024, an estimated $7.23K.
  • Quantbot Technologies first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 5 quarters.
  • Quantbot Technologies's Bicycle Therapeutics position peaked at $60K in Q2 2022.
  • 95 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2024.

Based on Quantbot Technologies's 13F filing for Q1 2024, filed 6 May 2024.